Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$64.4M |
| 2 |
DuPont de Nemours
DD
|
+$35.6M |
| 3 |
Alibaba
BABA
|
+$35.4M |
| 4 |
Apple
AAPL
|
+$34.3M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$28.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$88.3M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$46.6M |
| 3 |
NBIS
Nebius Group N.V.
NBIS
|
+$40.7M |
| 4 |
Comcast
CMCSA
|
+$38.1M |
| 5 |
PG&E
PCG
|
+$31.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.94% |
| 2 | Financials | 10.6% |
| 3 | Healthcare | 8.31% |
| 4 | Industrials | 7.75% |
| 5 | Consumer Discretionary | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Amgen
AMGN
$238B
| $3.06M | 0.06% |
+12,036
| New | +$2.98M |
|
277
BioMarin Pharmaceuticals
BMRN
$12.9B
| $3.04M | 0.06% |
39,948
-97,708
| -71% | -$9.89M |
|
|
SHLL.WS
278
DELISTED
Tortoise Acquisition Corp. Warrants, each whole warrant exercisable for one share of Class A common
SHLL.WS
| $3.04M | 0.06% |
+119,127
| New | +$1.53M |
|
279
L3Harris
LHX
$49.7B
| $2.98M | 0.06% |
17,571
-52,091
| -75% | -$9.14M |
|
280
JB Hunt Transport Services
JBHT
$25.9B
| $2.98M | 0.06% |
+23,586
| New | +$3.14M |
|
281
Vanguard Morningstar Mid-Cap Growth ETF
VOT
$19.7B
| $2.98M | 0.06% |
+16,534
| New | +$2.92M |
|
282
Philip Morris
PM
$293B
| $2.96M | 0.06% |
+39,477
| New | +$3.05M |
|
|
TLND
283
DELISTED
Talend S.A. American Depositary Shares
TLND
| $2.93M | 0.06% |
+75,000
| New | +$2.9M |
|
|
CMRC
284
Commerce.com Inc Series 1
CMRC
$184M
| $2.91M | 0.06% |
+34,985
| New | +$3.06M |
|
285
nCino
NCNO
$2.26B
| $2.91M | 0.06% |
+36,526
| New | +$2.92M |
|
|
RDS.B
286
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $2.91M | 0.06% |
120,000
+8,000
| +7% | +$229K |
|
287
Thermo Fisher Scientific
TMO
$233B
| $2.89M | 0.06% |
6,549
-14,168
| -68% | -$5.85M |
|
288
XPeng
XPEV
$11.7B
| $2.88M | 0.06% |
+143,731
| New | +$2.81M |
|
289
Kinsale Capital Group
KNSL
$8.74B
| $2.88M | 0.06% |
+15,152
| New | +$2.79M |
|
290
Vistra
VST
$45.7B
| $2.88M | 0.06% |
152,657
+10,407
| +7% | +$196K |
|
|
BBBY
291
DELISTED
Bed Bath & Beyond Inc
BBBY
| $2.86M | 0.06% |
190,774
+178,211
| +1,419% | +$2.06M |
|
|
MXIM
292
DELISTED
Maxim Integrated Products
MXIM
| $2.83M | 0.06% |
41,839
+15,576
| +59% | +$1.05M |
|
293
Sanofi
SNY
$110B
| $2.83M | 0.06% |
56,378
+24,397
| +76% | +$1.26M |
|
294
Pinterest
PINS
$13.3B
| $2.82M | 0.06% |
67,968
-51,323
| -43% | -$1.67M |
|
295
Illinois Tool Works
ITW
$80.4B
| $2.82M | 0.06% |
14,588
-847
| -5% | -$161K |
|
296
Ironwood Pharmaceuticals
IRWD
$709M
| $2.79M | 0.06% |
+310,483
| New | +$3.09M |
|
|
PDM
297
Piedmont Realty Trust
PDM
$1.21B
| $2.79M | 0.06% |
205,678
+92,819
| +82% | +$1.44M |
|
298
MongoDB
MDB
$34.7B
| $2.79M | 0.06% |
+12,045
| New | +$2.61M |
|
|
SJI
299
DELISTED
South Jersey Industries, Inc.
SJI
| $2.78M | 0.06% |
144,240
+109,323
| +313% | +$2.45M |
|
300
Equity Lifestyle Properties
ELS
$12.7B
| $2.77M | 0.06% |
45,267
+25,024
| +124% | +$1.62M |
|
Similar funds
Michael Gelband's Q3 2020 Portfolio in Review
As of Q3 2020, Michael Gelband held 2,471 positions worth $5.02B, up 30% from $3.85B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Michael Gelband deployed $816M of net new capital in Q3 2020, opening 743 new positions and adding to 409 existing holdings. Its largest new stake was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $46.6M trimmed.
- Michael Gelband's largest Q3 2020 buy was State Street Energy Select Sector SPDR ETF: 1,291,886 shares worth $19.3M.
- Michael Gelband added most to Charles Schwab in Q3 2020, an estimated $64.4M increase.
- Michael Gelband's biggest Q3 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $46.6M.
- Michael Gelband fully exited State Street SPDR S&P 500 ETF Trust in Q3 2020, selling an estimated $88.3M.
- Michael Gelband's ten largest holdings make up 32% of its $5.02B portfolio in Q3 2020.
- Michael Gelband opened 743 new positions and closed 789 in Q3 2020.
- Michael Gelband's portfolio value rose 30% quarter-over-quarter to $5.02B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.